Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

Thursday, February 8, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. has announced that it will host a conference call and webcast to discuss its fourth quarter and full year 2023 financial results. The event is scheduled for February 22, 2024, at 8:00 a.m. Eastern Time. Participants can register online for the call, which highlights the company’s commitment to transparency and communication with stakeholders. A replay will be available shortly after the event, ensuring accessibility to the information.
Price reaction · baseline $54.6 (2024-02-07 close) · hit after-hours · 1 other LNTH headline(s) in the window, move may be shared
day 0 close · peak
+1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is hosting a financial conference call, indicating transparency.
  • The event is focused on discussing positive financial and operational results.
  • Lantheus has over 65 years of experience in providing radiopharmaceutical solutions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 22, 2024, to discuss its financial and operating results for the fourth quarter and full year of 2023.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus's conference call scheduled?

The conference call is scheduled for February 22, 2024, at 8:00 a.m. ET.

How can participants access the conference call?

Participants can register for the conference call online at Lantheus's investor website.

When will the conference call replay be available?

A replay will be available approximately two hours after the event.

How long will the webcast recording be archived?

The webcast recording will be archived for at least 30 days.

What is Lantheus focused on?

Lantheus specializes in radiopharmaceuticals to improve patient outcomes.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus earnings call financial results radiopharmaceuticals
Last updated: Feb 8, 2024

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →